A simple supplement could help the immune system fight cancer and viruses
Low arginine levels may allow cancer cells and viruses to slip past the immune system by reducing production of a crucial cellular warning protein. In mice, arginine-rich diets led to fewer colon tumors and milder viral infections, suggesting a simple supplement could have powerful therapeutic potential.
The amino acid arginine plays a crucial role in supporting various bodily functions, including protein synthesis and immune system regulation. Low arginine levels have been associated with diseases such as colon cancer. A recent study published in Cell by researchers at Rockefeller University suggests that arginine deficiency may weaken the immune system and impair the body's ability to detect and eliminate cancerous or infected cells.
When arginine levels are low, cells struggle to produce MHC-1 proteins, which alert the immune system to potential threats. The study found that a moderate intake of arginine, equivalent to the amount found in a couple of over-the-counter tablets, could potentially restore the production of MHC-1 genes. The researchers propose that supplementing with arginine could be beneficial in combination with other treatments for cancer and viral infections.
The study's findings could lead to further research in patients undergoing immunotherapy or at high risk of viral infections. The researchers note that arginine is inexpensive and readily available, making it a promising candidate for further exploration. Previous research has shown that changes in amino acid availability can impact cellular metabolism and signaling, but the direct influence on gene expression remains less understood.
The new study provides evidence that arginine levels can directly affect gene expression, particularly in genes associated with MHC-1 protein production.
The researchers found that arginine deficiency was the most prevalent in several diseases, including colon cancer, influenza, and SARS-CoV-2. They identified 414 proteins that were present at unusually low levels due to arginine depletion. They discovered that arginine scarcity interfered with the production of MHC-1 proteins, which are essential for presenting foreign proteins to immune cells.
This interference allowed potentially dangerous cells to evade immune detection, contributing to the development and progression of diseases.
The study's findings have significant implications for understanding the relationship between nutrition, aging, and disease vulnerability. As arginine levels naturally decrease with age, poor diet, and aging can weaken the immune system's ability to recognize and eliminate abnormal or infected cells. The researchers suggest that age-related arginine loss may contribute to increased susceptibility to colon cancer and higher mortality rates from respiratory viruses.
The study's results open up new avenues for further investigation into the link between dietary manipulation, arginine levels, and gene expression in various diseases. The researchers are now exploring the potential of using arginine supplementation as a therapeutic and preventive strategy in patients receiving immunotherapy or those at risk of viral infections.
With its affordability and wide availability, arginine supplementation could offer a promising approach to enhancing immune system function and combatting various diseases.
Written by urgent.news from ScienceDaily Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
